5.1 Stakeholders

A successful AMR surveillance programme requires political support and strong engagement from the governmental body responsible for Public Health. The positioning of a national AMR programme alongside a governmental Public Health body reflects the national importance of AMR and policies designed to mitigate it.

Other important organisations include:

• national governmental bodies e.g. national doctors’ union, national pharmacy body
• national research agencies
• political parties, to make sure AMR remains high on the national agenda, and benefits from cross party agreement
• global health donors
• international development institutions
• international research-funding organisations
• aid and technical agencies.

These institutions should support countries in building capacity for collecting and analysing data on prevalence of AMR and facilitate the sharing and reporting of such data.